Peptide Science
In-depth articles on peptide research, mechanisms of action, and laboratory best practices — written for researchers.
BPC-157, TB-500 and GHK-Cu in preclinical tissue repair research — angiogenesis, migration and matrix findings, evidence tiered. For research use only.
Semax, Selank, and related neuromodulatory peptides in preclinical research — BDNF/NGF signaling, anxiolytic and GABAergic findings. For research use only.
Khavinson bioregulators are ultra-short synthetic peptides studied for a proposed direct peptide-DNA interaction mechanism and geroprotector effects in preclinical models.
Preclinical Selank research on GABAergic signaling, enkephalin mechanisms and anxiolytic peptide biology, with evidence clearly tiered. Research use only.
An evidence-led look at Semax research into BDNF and neurotrophic signaling, covering cerebral ischemia models, enkephalin-degrading enzyme inhibition, and the peptide's clinical registration context in Russia.
An evidence-led look at TB-500 research into Thymosin Beta-4 biology, covering the actin-binding domain, proposed mechanisms in cell migration and angiogenesis, and preclinical dermal and cardiac repair studies.
GHK-Cu is a copper-binding tripeptide studied for its effects on collagen synthesis and extracellular matrix biology, with newer preclinical research examining copper handling and neuroprotection in animal models.
An evidence-led look at BPC-157 research into tissue repair, covering proposed angiogenic mechanisms, tendon and ligament studies in rodent models, and the current absence of human trial data.
A receptor-biology look at Melanotan 2 research: peptide structure, melanocortin receptor agonism, and preclinical findings on the MC1R, MC3R, MC4R, and MC5R subtypes.
